1758 cases of malaria reported in UK travellers in 2006

NewsGuard 100/100 Score

New figures from the Health Protection Agency show that there were 1758 cases of malaria reported in UK travellers in 2006.

Eight of these cases were fatal.

1386 of the cases were due to the potentially fatal Plasmodium falciparum which is a major international health risk and which kills more than a million people a year in Africa. 219 were due to Plasmodium vivax which causes a debilitating disease, but is rarely fatal.

Where the reason for travel is known, 57% of the malaria cases reported in the UK were in people visiting friends and relatives in the tropics.

According to Professor Peter Chiodini, a malaria expert at the HPA “It is a common misconception that people who were born in places where malaria is rife and who now live in the UK, have immunity to malaria. This is not the case because they very quickly lose the partial immunity they might have acquired whilst they lived there, and people who have never lived in these countries have no immunity.”

“It is particularly important that people are aware that they are at risk if they do not follow advice on malaria prevention.”

Also in 2006 there was the first imported case of Plasmodium knowlesi (a primate malaria parasite found in parts of Southeast Asia which can occasionally be transmitted to humans). P.knowlesi infection of humans can be prevented in the same way as for other malaria parasites. Whilst of interest, the appearance of this parasite should not distract attention from the serious problems posed by P.falciparum .

Malaria can be caught through the bite of an Anopheles mosquito. It is a potentially life-threatening illness and although it is preventable, many travellers put themselves at risk by not taking the appropriate protective drugs, or not completing the course.

As summer holidays approach, it is essential that travellers to destinations where malaria is present ensure they plan ahead by seeking pre-travel medical advice on which preventive drugs and other measures are appropriate for their destination. A course of such drugs should be started prior to travel and be continued for the whole period advised after returning to the UK.

Equally as important as protective drugs are measures to prevent mosquito bites and these should also be followed carefully when travellers are abroad. These include applying insect repellent, wearing cover-up clothing and sleeping under an insecticide-treated bed net.

There must be no delay in seeking medical attention in the event of a fever developing within a year of leaving a malarious area, as delayed diagnosis increases the risk of death.

Professor Chiodini said, “It is important for travellers to be aware of the symptoms of malaria, which can be very similar to those of flu. Cases in this country are regularly diagnosed late, which can lead to a more severe illness, so if you become unwell after returning from the tropics, passing on your travel history to your doctor and mentioning the possibility of malaria is crucial.”

Notes to Editors

  • For further information please contact the HPA Centre for Infections press office on 020 8327 6690/7097/7098.
  • Today's data contrast with the pattern of 20 years ago when P. vivax was the predominant imported species. In 1987 there were 1005 cases of P. vivax and only 696 cases of P. falciparum.
    P. falciparum , is now responsible for 79% of malarias imported into the UK so, although the total number of cases has not changed very much, the overall situation is more serious.
  • Malaria is a preventable parasitic disease transmitted by mosquitoes. It is predominantly a disease affecting Africa, South and Central America, Asia, Oceania and the Middle East .
  • The symptoms of malaria include a flu-like illness, fever, shaking, headache, muscle aches and tiredness. Nausea, vomiting and diarrhoea may also occur.
  •  If travellers develop these symptoms whilst abroad or up to one year after returning, they should seek prompt medical advice and tell their doctor they have been in an area where malaria is a hazard.
  • Members of the public should seek advice about their specific travel health needs from their GP or local travel clinic. An information sheet on insect bite avoidance and updates on other travel health issues are available on the National Travel Health Network and Centre (NaTHNaC) website at www.nathnac.org/travel/factsheets/iba.htm and www.nathnac.org/travel/news/index.htm which deals with queries about patients with complex medical needs or travel itineraries.
  • The risks posed by malaria in some countries change over time. Health professionals who require assistance and more specialist advice when advising travellers should contact the HPA Malaria Reference Laboratory (0207 636 3924) or NaTHNaC (0845 602 6712).
  • Malaria has a massive impact on human human health; it is the world's second biggest killer after tuberculosis. Around 300 million clinical cases occur each year resulting in between 1.5 - 2.7 million deaths annually, the majority in sub-saharan Africa . It is estimated that 3,000 children under the age of five years fall victim to malaria each day. Around 40 % of the worlds population are at risk and it is not known how this might be affected by possible climate change. The societies and economic development of some of the world's poorest nations are severely affected by malaria.

The HPA has published guidelines on the prevention of malaria in travellers at

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
WHO recommends R21/Matrix-M vaccine for malaria prevention in children